# Stereotactic Body Radiotherapy for the Treatment of OPD

> **NCT03256981** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Institute of Cancer Research, United Kingdom** · enrollment: 113 (actual)

## Conditions studied

- NSCLC

## Interventions

- **RADIATION:** SBRT
- **DRUG:** TKI

## Key facts

- **NCT ID:** NCT03256981
- **Lead sponsor:** Institute of Cancer Research, United Kingdom
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-27
- **Primary completion:** 2023-07-17
- **Final completion:** 2025-06-30
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256981, "Stereotactic Body Radiotherapy for the Treatment of OPD". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03256981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*